Trenton, September 27, 2025 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, issued the following statement concerning the White House announcement on pharmaceutical company tariffs:
“New Jersey’s life sciences share the goal of strengthening America’s national security and manufacturing supply chain while remaining the global leader in medical innovation. We will continue working with all stakeholders to strike the right balance of urgency in the immediate term, but we must ensure we don’t unintentionally jeopardize patients, medical advances or New Jersey jobs as we do so.”